Mastery EAQ Ch. 34

A  Decreased pain

B  Strong contractions

C  Softened cervix

D  Midline fundus

A  Abnormal vaginal bleeding

B  Renal failure

C  Ovarian failure

D  Pulmonary embolism

A  Blurred vision, Bradycardia, Increased diuresis

B  Anxiety, Dizziness, Blurred vision

C  Hirsutism, Dizziness,, Increased diuresis

D  Hirsutism, Bradycardia, Increased diuresis

A  During the entire period the patient is taking the antibiotic

B  For at least 1 month after starting the antibiotic

C  Until three throat cultures have been negative for the pathogen

D  For at least 6 weeks, starting at the end of the antibiotic regimen

A  Estradiol

B  Megestrol

C  Methylergonovine

D  Alendronate

A  Protamine sulfate

B  Calcium gluconate

C  Atropine

D  Epinephrine

A  Request a prescription to give calcium gluconate.

B  Obtain a prescription for indomethacin.

C  Obtain a prescription for terbutaline.

D  Decrease the drug dose immediately.

A  Immediately discontinue intravenous (IV) fluids.

B  Administer phentolamine mesylate.

C  Place the patient on her left side.

D  Instruct the patient to bear down and push.

A  Administer it before placenta delivery. Monitor blood pressure during administration. Assess for pelvic inflammatory disease. Question the prescription if the patient has liver disease.

B  Monitor the patient for blurred vision. Administer it before placenta delivery. Assess for pelvic inflammatory disease. Question the prescription if the patient has liver disease.

C  Monitor the patient for blurred vision. Monitor blood pressure during administration. Assess for pelvic inflammatory disease. Question the prescription if the patient has liver disease.

D  Monitor the patient for blurred vision. Monitor blood pressure during administration. Administer it before placenta delivery. Question the prescription if the patient has liver disease.

A  Nausea and vomiting

B  Uterine atony

C  Hypertension

D  Pelvic inflammatory disease

A  Uterine contractions

B  Blood glucose

C  Blood pressure

D  Temperature

A  Ineffective contractions in a full-term pregnancy

B  Radiographic confirmation of cephalopelvic disproportion

C  Vaginal bleeding at 38 weeks’ gestation

D  Absence of cervical ripening at 42 weeks’ gestation

A  Low fluid intake

B  Cigarette use

C  Current tricyclic antidepressant use

D  Use of herbal supplements

A  The patient’s blood pressure and pulse, Complete blood cell count, Uterine hyperactivity

B  Fetal heart rate, Fetal movement, The patient’s blood pressure and pulse

C  Fetal movement, Uterine hyperactivity, Complete blood cell count

D  Uterine hyperactivity, Fetal heart rate, Complete blood cell count

A  Calcitonin

B  Ibandronate

C  Denosumab

D  Tamoxifen

A  Persuade the patient to start the therapy.

B  Advise the patient to engage in quiet activities.

C  Ask the patient to include soy in her diet.

D  Inform the patient about the benefits and risks of the therapy.

A  “The treatment should be started as soon as possible.”

B  “The treatment is likely to cause endometrial cancer.”

C  “You may need to stop smoking during the therapy.”

D  “The therapy may cause thromboembolic events.”

A  Ritodrine

B  Terbutaline

C  Bed rest and hydration

D  Magnesium sulfate

A  Antibiotic therapy

B  Hypertension

C  Anticonvulsant therapy

D  Diabetes

A  Male condom with spermicidal jelly

B  Norethindrone and ethinyl estradiol

C  Medroxyprogesterone

D  Cervical cap with spermicidal jelly

A  Current smoker

B  Joint pain

C  Breast cancer

D  Allergy to salmon

A  “Discontinue the calcium supplement.”

B  “Obtain a prescription for increasing the bisphosphonate dose.”

C  “Space the medications 1 to 2 hours apart.”

D  “Replace the bisphosphonate with calcitonin.”

A  “Perform weight-bearing exercise.”

B  “Report missed menstrual periods.”

C  “Have tests for serum cholesterol.”

D  “Have a yearly mammogram.”

A  “High progesterone levels inhibit the release of luteinizing hormone.”

B  “Estrogen levels inhibit the release of follicle-stimulating hormone.”

C  “Surges of Gn-RH, follicle-stimulating hormone, and luteinizing hormone stimulate ovulation.”

D  “Decreased Gn-RH suppresses the release of follicle-stimulating hormone.”

A  “I have seen a great improvement in my sexual desire.”

B  “I no longer experience hot flashes.”

C  “I have not experienced any uterine bleeding.”

D  “I am no longer experiencing painful intercourse.”

A  Metformin

B  Amoxicillin

C  Ferritin

D  Levothyroxine

A  Contains estrogen, which stimulates bone reabsorption

B  Promotes bone absorption of calcium

C  Inhibits osteoclast-mediated bone reabsorption

D  Stimulates estrogen receptors on the bone to increase bone density

A  Levothyroxine, Multivitamin

B  Atenolol, Levothyroxine

C  Warfarin, Cholestyramine

D  Multivitamin, Atenolol

A  “This medication will help relieve the bone pain I have from my osteoporosis.”

B  “I need to take this medication with food to prevent damage to my esophagus.”

C  “I need to decrease my intake of dairy products to prevent hypercalcemia.”

D  “I will take the medication on an empty stomach and not lie down for 30 minutes.”

A  Chest pain, Hot flashes, Loss of appetite

B  Hot flashes, Loss of appetite, Joint pain

C  Vertigo, Joint pain, Chest pain

D  Hot flashes, Vertigo, Loss of appetite

A  To terminate pregnancy

B  To treat pelvic inflammatory disease

C  To induce cervical ripening

D  To treat gestational hypertension

A  Increased body mass index (BMI)

B  Smoking heavily every day

C  Consumption of saturated fats

D  Sedentary lifestyle

A  Monotherapy with a progestin increases breast cancer risk.

B  Estradiol with progestin increases the risk of endometrial cancer.

C  Estrogen monotherapy increases the risk of breast cancer.

D  Unopposed estrogen increases the risk of endometrial cancer.

A  Terbutaline

B  Oxytocin

C  Clomiphene

D  Prostaglandin E

A  Megestrol

B  Medroxyprogesterone

C  Estropipate

D  Estrone

A  Loss of hair

B  Brown discoloration of face

C  Yellow undertone to the skin

D  Hot flashes

A  Monitor the patient’s blood pressure frequently.

B  Administer acetaminophen as needed.

C  Assess pulse oximetry continuously.

D  Suggest the patient take aluminum hydroxide with the medication.

A  Dinoprostone

B  Indomethacin

C  Clomiphene

D  Oxytocin

A  Clomiphene

B  Progesterone

C  Choriogonadotropin alfa

D  Ethinyl estradiol

A  Uterine bleeding

B  Weight loss

C  Deep vein thrombosis

D  Dysmenorrhea

A  “Vaginal cancer is prevented by adding progestin to the regimen.”

B  “Endometrial cancer risk can be reduced by adding progestin.”

C  “The progestin in the regimen will help prevent ovarian cancer.”

D  “The progestin in the regimen will help prevent breast cancer.”

A  Diminished endometrial tissue proliferation

B  Interference with the proliferation of the fertilized ovum

C  Elevated progesterone levels inhibiting the release of the luteinizing hormone

D  Inhibition of the release of gonadotropins

A  Follicle-stimulating hormone

B  Antidiuretic hormone

C  Adrenocorticotropic hormone

D  Luteinizing hormone

A  Thrombophlebitis

B  Dysmenorrhea

C  Hypertension

D  Weight gain

A  Dry skin

B  Nausea

C  Higher-pitched voice

D  Weight loss

A  Postpartum hemorrhage

B  Termination of pregnancy

C  Accelerated labor

D  Premature labor

A  Esterified estrogens

B  Alendronate

C  Medroxyprogesterone

D  Megestrol

A  Phase 3

B  Phase 1

C  Phase 2

D  Phase 4

A  Extended-cycle

B  Biphasic

C  Triphasic

D  Monophasic

A  Follicle-stimulating hormone (FSH)

B  Luteotropic hormone

C  Luteinizing hormone (LH)

D  Interstitial cell-stimulating hormone

A  Megestrol

B  Methylergonovine

C  Medroxyprogesterone acetate

D  Indomethacin

A  Methylergonovine

B  Oxytocin

C  Magnesium sulfate

D  Terbutaline

A  Megestrol

B  Methylergonovine

C  Raloxifene

D  Clomiphene

A  Day 7

B  Day 21

C  Day 14

D  Day 3

A  Antidiuretic hormone

B  Follicle-stimulating hormone (FSH)

C  Luteinizing hormone (LH)

D  Adrenocorticotropic hormone

A  The patient’s blood pressure is stable.

B  The patient is ready for delivery.

C  The contractions can be fatal to the patient.

D  The fetal heart rate is stable.

A  Current smoking status

B  Current use of medications for depression

C  Compliance with the fertility drugs

D  Presence of abnormal uterine bleeding

A  Dementia, Ovarian cancer, Cigarette smoking, Cardiovascular disease, Serious cardiovascular events

B  Dementia, Breast cancer, Ovarian cancer, Cardiovascular disease, Serious cardiovascular events

C  Dementia, Breast cancer, Cigarette smoking, Cardiovascular disease, Ovarian cancer

D  Dementia, Breast cancer, Cigarette smoking, Cardiovascular disease, Serious cardiovascular events